317 related articles for article (PubMed ID: 34517044)
1. Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
Hara H; Uemura Y; Hayakawa K; Togano T; Asai Y; Matsunaga N; Terada M; Ohtsu H; Kitajima K; Shimizu Y; Sato L; Ishikane M; Kinoshita-Iwamoto N; Shibata T; Kondo M; Izumi K; Sugiura W; Ohmagari N
Int J Infect Dis; 2021 Nov; 112():111-116. PubMed ID: 34517044
[TBL] [Abstract][Full Text] [Related]
2. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
Togano T; Uemura Y; Asai Y; Hayakawa K; Matsunaga N; Terada M; Ohtsu H; Suzuki S; Toyoda A; Hara H; Sato R; Ishikane M; Kinoshita-Iwamoto N; Hangaishi A; Ohmagari N
J Infect Chemother; 2021 Oct; 27(10):1498-1503. PubMed ID: 34340930
[TBL] [Abstract][Full Text] [Related]
3. The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study.
Tessema AG; Mengiste ZM; Hundie TG; Yosef HG; Huluka DK; Seyoum AB; Abate HK; Howe RC
BMC Pulm Med; 2023 Mar; 23(1):85. PubMed ID: 36915064
[TBL] [Abstract][Full Text] [Related]
4. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
5. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
7. Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.
Hsu A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
Thromb Res; 2020 Dec; 196():375-378. PubMed ID: 32980620
[TBL] [Abstract][Full Text] [Related]
8. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan.
Fujiwara S; Nakajima M; Kaszynski RH; Fukushima K; Tanaka M; Yajima K; Kobayashi T; Sekiya N; Yamamoto Y; Miwa M; Ishihata A; Yamauchi Y; Yamamoto K; Goto H; Imamura A
J Infect Chemother; 2021 Jun; 27(6):869-875. PubMed ID: 33663933
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
[TBL] [Abstract][Full Text] [Related]
11. The association of anticoagulation before admission and survival of patients with COVID-19.
Kuno T; Takahashi M; So M; Egorova NN
J Cardiol; 2022 Apr; 79(4):489-493. PubMed ID: 34974942
[TBL] [Abstract][Full Text] [Related]
12. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
[TBL] [Abstract][Full Text] [Related]
14. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
15. Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kosior DA; Undas A; Kopeć G; Hryniewiecki T; Torbicki A; Mularek-Kubzdela T; Windyga J; Pruszczyk P
Kardiol Pol; 2020 Jun; 78(6):642-646. PubMed ID: 32515570
[TBL] [Abstract][Full Text] [Related]
16. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
17. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan.
Matsunaga N; Hayakawa K; Terada M; Ohtsu H; Asai Y; Tsuzuki S; Suzuki S; Toyoda A; Suzuki K; Endo M; Fujii N; Suzuki M; Saito S; Uemura Y; Shibata T; Kondo M; Izumi K; Terada-Hirashima J; Mikami A; Sugiura W; Ohmagari N
Clin Infect Dis; 2021 Dec; 73(11):e3677-e3689. PubMed ID: 32986793
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.
Ito Y; Awano N; Uchiyama F; Inomata M; Kuse N; Tone M; Takada K; Fujimoto K; Muto Y; Sagisaka S; Maki K; Yamashita R; Harada A; Nishimura JI; Hayashi M; Izumo T
Intern Med; 2021 Nov; 60(21):3503-3506. PubMed ID: 34433713
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.
Worth H; Helmlinger K; Raj R; Heidel E; Lands R
Clin Appl Thromb Hemost; 2021; 27():10760296211053315. PubMed ID: 34786969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
